Fundraising Fox
/People
Sign in

Habib Dable

Investor

Advisor at RA Capital

Cambridge, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Habib

534 people in our graph can introduce you to Habib.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Sam Blackman to introduce you to Habib

You →Sam · together at Day One Biopharmaceuticals (2024–2026) →Habib

Ask Jamie Chen to introduce you to Habib

You →Jamie · 11 people · together at RA Capital →Habib

Sign up to find every way you can get introduced to Habib

  • Your email: the people you already email who know Habib
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Habib
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Habib Dable is an Advisor at Raven, where he advises and supports new companies, portfolio companies, and executives. He previously spent five years as President and CEO of Acceleron Pharma, which was acquired by Merck in 2021, and earlier held leadership roles over roughly 22 years at Bayer AG, including President, U.S. Pharmaceuticals. He holds a BBA and MBA from the University of New Brunswick and completed executive programs at Stanford University and Korn/Ferry.

Invests in

Biotech

Experience

  1. RA Capital Management, L.P.Advisorcurrent2022 — presentBoston, Massachusetts, United States
  2. Atavistik BioBoard Membercurrent2026 — presentCambridge, Massachusetts, United States
  3. Tyra BiosciencesIndependent Board Directorcurrent2026 — presentCarlsbad, California, United States
  4. SpyGlass Pharma, Inc.Independent Board Directorcurrent2026 — presentIrvine, California, United States
  5. Relay TherapeuticsIndependent Board Directorcurrent2025 — presentCambridge, Massachusetts, United States
  6. PepGenIndependent Board Directorcurrent2022 — presentCambridge, Massachusetts, United States
  7. BIOLINK.orgBoard Membercurrent2022 — present
  8. Day One BiopharmaceuticalsIndependent Board Director2024 — 2026Brisbane, California, United States
  9. Blueprint MedicinesIndependent Board Director2022 — 2025Cambridge, Massachusetts, United States
  10. Aerovate Therapeutics, Inc.Board Chair2024 — 2025
  11. Aerovate Therapeutics, Inc.Independent Board Director2023 — 2025Cambridge, Massachusetts, United States
  12. Albireo Pharma, Inc.Independent Board Director2022 — 2023Cambridge, Massachusetts, United States
  13. Acceleron PharmaPresident & CEO2016 — 2021Cambridge, Massachusetts
  14. MILLENDO THERAPEUTICSIndependent Board Director2018 — 2021Ann Arbor, Michigan
  15. Biotechnology Innovation OrganizationMember Board Of Directors2016 — 2017
  16. BayerPresident, U.S. Pharmaceuticals2015 — 2016Whippany, New Jersey
  17. BayerEVP, Global Head Specialty Medicine2013 — 2015Whippany, New Jersey
  18. BayerVP Ophthalmology & Global Launch Team Head - EYLEA®2010 — 2012Whippany, New Jersey
  19. BayerGlobal Head TA Neurology / Ophthalmology2008 — 2009Whippany, New Jersey
  20. BayerVP & Regional Business Unit Head2005 — 2008Berkeley, California
  21. BayerDirector, Int'l Sales & Marketing2003 — 2004Raleigh-Durham, North Carolina
  22. BayerHead of Strategic Planning2000 — 2002Osaka, Japan
  23. BayerArea Sales Manager1999 — 2000Atlantic Canada
  24. BayerProduct Manager / Management Trainee1997 — 1999Toronto, Canada
  25. BayerMedical Sales Representative1994 — 1997New Brunswick, Canada

Skills & more

Languages Arabic · English · Japanese

From Habib's professional profile.

Colleagues at RA Capital

Abigail Greely
IT Business Analyst at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adam Prince
Senior Associate, Strategic Initiatives at RA Capital
Adam Travis
Vice President, Corporate Development at RA Capital
Adison Greene
Senior Executive Assistant at RA Capital
Adrian Bot
Venture Partner at RA Capital
Alana MacDonald
Senior Associate at RA Capital

Frequently asked questions

Who is Habib Dable?
Habib Dable is an Advisor at Raven, where he advises and supports new companies, portfolio companies, and executives. He previously spent five years as President and CEO of Acceleron Pharma, which was acquired by Merck in 2021, and earlier held leadership roles over roughly 22 years at Bayer AG, including President, U.S. Pharmaceuticals. He holds a BBA and MBA from the University of New Brunswick and completed executive programs at Stanford University and Korn/Ferry.
Where does Habib Dable work?
Habib Dable is Advisor at RA Capital.
What does Habib Dable invest in?
Habib Dable invests in Biotech.
What check size does Habib Dable write?
Habib Dable typically writes checks of $100K – $5M.
Where did Habib Dable go to school?
Habib Dable studied at University of New Brunswick (Master of Business Administration - MBA, 1994); University of New Brunswick (Bachelor of Business Administration - BBA, 1991); Stanford University Graduate School of Business (Stanford Executive Program, 2007).

Same school

Shared employers